Specifically, MCP-1 could be involved in the migration and localization of FL cells [115] and, together with its receptor (CCR2), has been suggested as a good factor to better identify DLBCL patients with high-risk by the international prognostic index since the high expression of these proteins has been associated with poor overall survival and progression-free survival [116]. Here, CCL2 is linked to diffuse large B-cell lymphoma.